Come up with a name for your new list and we'll add to it:
Nexcelom Bioscience raised a round of funding on March 20, 2018. Investors include
Ampersand Capital Partners.
Nexcelom Bioscience designs, develops, and manufactures devices and instruments for cell-based assays used in cancer research, vaccine development, stem cell research, infectious disease treatment, an…